Obstetric and Neonatal Outcomes of Cancer Treated During Pregnancy

被引:12
|
作者
Walton, Janelle R. [2 ]
Prasad, Mona R. [1 ]
机构
[1] Ohio State Univ, Div Maternal Fetal Med, Med Ctr, Dept Obstet & Gynecol,Coll Med, Columbus, OH 43210 USA
[2] Northwestern Univ, Div Maternal Fetal Med, Dept Obstet & Gynecol, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
cancer; pregnancy; malignancy; treatment; CHEMOTHERAPY IN-UTERO; BREAST-CANCER; SURGICAL INTERVENTION; HODGKINS-DISEASE; PRETERM BIRTH; CHILDREN; RADIOTHERAPY; MALIGNANCY; MANAGEMENT;
D O I
10.1097/GRF.0b013e318236e781
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Cancer diagnosed during pregnancy is a rare occurrence with an incidence of 0.1% of all pregnancies. However, its management can be challenging at times as one balances maternal benefit to fetal risk. Various treatment modalities are used in this context including surgical intervention, chemotherapy, and radiologic therapy. This review seeks to address the impact of pregnancy on disease as well as the effect of malignancy and its treatment on both mother and fetus. Attention is focused on the more common malignancies associated with pregnancy: cervix, breast, melanoma, and hematologic malignancies. In addition, special emphasis is placed on timing of delivery and how that affects neonatal outcomes.
引用
收藏
页码:567 / 573
页数:7
相关论文
共 50 条
  • [1] Management of Cancer During Pregnancy Obstetric and Neonatal Outcomes
    Lataifeh, Isam M.
    Al Masri, Mahmoud
    Barahmeh, Samer
    Otay, Lian
    Obeidat, Nail
    Badran, Osama
    Darwazeh, Ghaleb
    Jaradat, Imad
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (06) : 1159 - 1164
  • [2] Obstetric and neonatal outcomes following taxane use during pregnancy: a systematic review
    Aranda-Gutierrez, Alejandro
    Ferrigno Guajardo, Ana S.
    Vaca-Cartagena, Bryan F.
    Gonzalez-Sanchez, David G.
    Ramirez-Cisneros, Arantxa
    Becerril-Gaitan, Andrea
    Azim, Hatem A.
    Villarreal-Garza, Cynthia
    BMC CANCER, 2024, 24 (01)
  • [3] Management of cancer during pregnancy and current evidence of obstetric, neonatal and pediatric outcome: a review article
    Maggen, Charlotte
    van Gerwen, Mathilde
    Van Calsteren, Kristel
    Vandenbroucke, Tineke
    Amant, Frederic
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (02) : 404 - 416
  • [4] Cancer in Pregnancy: Fetal and Neonatal Outcomes
    Backes, Carl H.
    Moorehead, Pamela A.
    Nelin, Leif D.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2011, 54 (04) : 574 - 590
  • [5] Chemotherapy against cancer during pregnancy: A systematic review on neonatal outcomes
    Esposito, Susanna
    Tenconi, Rossana
    Preti, Valentina
    Groppali, Elena
    Principi, Nicola
    MEDICINE, 2016, 95 (38)
  • [6] Gout in pregnancy: Obstetric and neonatal outcomes
    Amar, Sam
    Badeghiesh, Ahmad
    Baghlaf, Haitham
    Dahan, Michael H.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2025, 169 (01) : 349 - 355
  • [7] BREAST CANCER DURING PREGNANCY: THE OBSTETRIC AND PERINATAL OUTCOMES OF 11 CASES
    Ozel, Aysegul
    Alici Davutoglu, Ebru
    Yilmaz, Nevin
    Madazli, Riza
    JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2016, 79 (02): : 61 - 65
  • [8] Obstetric and neonatal outcomes following taxane use during pregnancy: a systematic review
    Alejandro Aranda-Gutierrez
    Ana S. Ferrigno Guajardo
    Bryan F. Vaca-Cartagena
    David G. Gonzalez-Sanchez
    Arantxa Ramirez-Cisneros
    Andrea Becerril-Gaitan
    Hatem A. Azim
    Cynthia Villarreal-Garza
    BMC Cancer, 24
  • [9] Influence of cancer in pregnancy on obstetric and neonatal outcomes: an observational retrospective cohort study
    Huang, Xuan
    Zhang, Chen
    Zhu, Jialei
    Li, Yueyan
    Tang, Jing
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 35 (06)
  • [10] Breast cancer during pregnancy
    Loibl, S.
    ONKOLOGE, 2012, 18 (04): : 338 - 343